Form 4: Tenet Healthcare Director Sells Over 1,200 Shares of Common Stock

J. Robert Kerrey, a Director at Tenet Healthcare Corp, reported the sale of 1,222 shares of common stock for approximately $201,500.

Summary

• J. Robert Kerrey, a Director of Tenet Healthcare Corp (THC), disposed of 1,222 shares of common stock on May 27, 2025.
• The shares were sold at a weighted average price of $164.96 per share, with individual transaction prices ranging from $164.48 to $165.25.
• Following this transaction, Mr. Kerrey beneficially owns 22,377 shares of Tenet Healthcare common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to insider selling, though the transaction was pre-planned under Rule 10b5-1, which mitigates some of the negative perception. The number of shares sold is also a relatively small portion of the director's total holdings.

Negatives

• A director selling shares, even if pre-planned, can sometimes be perceived negatively by the market as it reduces insider ownership.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends within the healthcare sector.

Stakeholder Impact

• Shareholders: The sale by a director could be interpreted as a slight negative signal, though the pre-planned nature (Rule 10b5-1) suggests it's not based on new, adverse information.

Key Dates

Keywords

Tenet Healthcare, THC, SEC Form 4, Insider Trading, Stock Sale, Director, J. Robert Kerrey, Healthcare, Beneficial Ownership